A Prospective Randomized Open-label 6-Month Head-To-Head Trial to Evaluate the Safety and Tolerability of Paliperidone ER and Olanzapine in Subjects with Schizophrenia

Update Il y a 4 ans
Reference: EUCTR2006-006967-22

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective is to show that paliperidone is superior to olanzapine in the improvement of the triglyceride to high density lipoprotein ratio (TG:HDL ratio)


Inclusion criteria

  • Schizophrenia